Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Control Bionics.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX tracks global selloff; Yancoal and GYG amongst new ASX200 entrants
Health & Biotech
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
Health & Biotech
Digital prescription: ASX stocks transforming healthcare sector
Stockhead TV
Long Shortz with Control Bionics: Major MedTech milestone with new US recognition
Health & Biotech
CBL lifts on NeuroNode’s approval as reimbursable medical device in US
News
ASX Small Caps Lunch Wrap: ASX struggles for traction as earnings fling some very sticky mud
Health & Biotech
ASX Health Stocks: CBL targets more reimbursement revenue for NeuroNode device
News
Closing Bell: Intense relief as ASX rallies on easing inflation
Health & Biotech
NorthStar sees good impact in Control Bionics, invests $525k
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Has anyone else noticed something’s up with the water this week?
Health & Biotech
ASX Health Stocks: Control Bionics surges over 50pc after TGA approval of DROVE wheelchair
News
Top 10 at 10: High tech wheelchairs, copper discoveries, and a big uranium bounty
News
Market Highlights: GYG and VanEck’s Bitcoin ETF to make ASX debut today, and 5 small caps to watch
Tech
Control Bionics on track to harness the power of AI for good
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
